A protein called NAMPT in fat cells may help prevent obesity-related metabolic problems like inflammation, poor blood sugar control, and fatty liver disease, according to a 2026 Gram Research analysis published in Diabetes. When researchers increased NAMPT levels in obese mice, the animals were protected from these metabolic complications, and tiny cellular packages from these enhanced fat cells improved glucose tolerance in other obese mice. However, this is early-stage animal research, and human treatments are years away.
Scientists discovered that a protein called NAMPT in fat cells plays a crucial role in preventing weight-related health problems. When researchers boosted NAMPT levels in obese mice, the animals were protected from inflammation, blood sugar problems, and fatty liver disease. Even more exciting, tiny packages called extracellular vesicles released by these enhanced fat cells improved glucose tolerance in other obese mice. This 2026 study published in Diabetes suggests that NAMPT could be a new target for treating metabolic diseases linked to obesity.
Key Statistics
A 2026 research article in Diabetes found that mice with adipocyte NAMPT overexpression were protected from diet-induced metabolic dysfunction, including adipose tissue inflammation, glucose intolerance, and hepatic steatosis.
According to Gram Research analysis of a 2026 Diabetes study, extracellular vesicles from NAMPT-overexpressing mice improved glucose tolerance when transferred into obese mice, demonstrating that fat cells can communicate metabolic benefits to other tissues.
A 2026 study published in Diabetes revealed that adipose tissue extracellular vesicles from NAMPT-enhanced mice exhibited marked changes in lipid and metabolite cargo compared to regular mice, suggesting altered cell-to-cell communication pathways.
The Quick Take
- What they studied: Whether increasing a protein called NAMPT in fat cells could prevent the metabolic problems that come with obesity, such as inflammation, poor blood sugar control, and fatty liver disease.
- Who participated: Laboratory mice, including obese mice and mice genetically engineered to overproduce NAMPT in their fat cells. The study compared how these different groups responded to a high-fat diet.
- Key finding: Mice with extra NAMPT in their fat cells were protected from diet-induced metabolic dysfunction, including reduced fat tissue inflammation, improved glucose tolerance, and less fatty liver disease compared to regular obese mice.
- What it means for you: This research identifies a potential new treatment target for obesity-related metabolic diseases in humans. However, these are early-stage animal studies, and it will take years of additional research before any human treatments become available. People with obesity or metabolic disorders should continue following current medical advice from their healthcare providers.
The Research Details
Researchers created genetically modified mice that produced extra amounts of a protein called NAMPT specifically in their fat cells. They then fed these mice a high-fat diet to see if the extra NAMPT would protect them from the metabolic problems that normally develop with obesity. The scientists compared these enhanced mice to regular mice on the same diet, measuring inflammation markers, blood sugar control, and liver fat accumulation.
The researchers also collected tiny cellular packages called extracellular vesicles from the fat tissue of the enhanced mice and transferred them into obese mice to test whether these packages alone could improve metabolic health. This allowed them to identify which components of the fat cells were responsible for the protective effects.
The team analyzed the contents of these vesicles to understand what molecules they carried that might explain their beneficial effects on metabolism.
This research approach is important because it identifies a specific protein and mechanism that could be targeted with future drugs. By using genetically modified mice, scientists can prove that NAMPT directly causes the protective effects rather than just being associated with them. Testing whether vesicles alone can transfer benefits helps narrow down which molecules are actually responsible, making it easier to develop targeted treatments.
This study was published in Diabetes, a peer-reviewed scientific journal with high credibility in metabolic research. The research used controlled laboratory conditions with genetically modified animals, which allows for precise testing of cause-and-effect relationships. However, animal studies don’t always translate directly to humans, so results should be considered preliminary. The study appears to be well-designed with appropriate controls, though the specific sample sizes weren’t provided in the abstract.
What the Results Show
Mice engineered to overproduce NAMPT in their fat cells showed remarkable protection against the metabolic problems caused by a high-fat diet. These enhanced mice had significantly less inflammation in their fat tissue compared to regular obese mice, which is important because fat tissue inflammation is a major driver of metabolic disease.
The NAMPT-enhanced mice also showed better glucose tolerance, meaning their bodies handled blood sugar more effectively. This is a key marker of metabolic health and suggests the mice were less likely to develop diabetes. Additionally, these mice had less fat accumulation in their livers, a condition called hepatic steatosis that often accompanies obesity and can lead to liver disease.
When researchers isolated extracellular vesicles from the enhanced mice’s fat tissue and transferred them into obese mice, the recipient mice showed improved glucose tolerance. This finding was particularly significant because it demonstrated that the beneficial effects could be transferred through these tiny cellular packages, suggesting specific molecules within the vesicles were responsible for the improvements.
Analysis of the vesicle contents revealed marked changes in their lipid and metabolite cargo compared to vesicles from regular mice, indicating that the NAMPT overexpression altered what molecules the fat cells were shipping out to other parts of the body.
The study revealed that NAMPT works by affecting NAD+, a critical molecule involved in energy metabolism and cellular health. By increasing NAMPT, the fat cells produced more NAD+, which appears to improve their overall metabolic function. The changes in vesicle contents suggest that enhanced fat cells communicate with other tissues through these molecular packages, potentially improving whole-body metabolism. This communication pathway between fat tissue and other organs could be important for understanding how local changes in fat cells affect overall metabolic health.
Previous research had shown that NAD+ levels and NAMPT activity are reduced in obese individuals and that this reduction contributes to metabolic problems. This study builds on that foundation by demonstrating that simply restoring or increasing NAMPT can reverse these problems. The finding that extracellular vesicles mediate some of these benefits is novel and opens new research directions, as most previous work focused on direct effects within fat cells rather than cell-to-cell communication.
This research was conducted in mice, which have different metabolism and physiology than humans, so results may not directly apply to people. The study doesn’t specify exact sample sizes, making it difficult to assess statistical power. The research focused on genetic overexpression of NAMPT, which is different from using a drug to increase NAMPT activity—a more practical approach for human treatment. Long-term effects weren’t measured, so it’s unclear whether the benefits persist over extended periods. Additionally, the study examined only one aspect of metabolic dysfunction and didn’t test whether NAMPT enhancement could reverse existing obesity or metabolic disease, only prevent it from developing.
The Bottom Line
Based on this research, NAMPT represents a promising target for future drug development to treat obesity-related metabolic diseases. However, these findings are preliminary and based on animal studies. Current evidence-based recommendations for managing metabolic dysfunction remain: maintain a healthy weight through balanced nutrition, engage in regular physical activity, and work with healthcare providers on personalized treatment plans. Do not change your current medical treatment based on this research alone.
People with obesity, prediabetes, type 2 diabetes, or fatty liver disease should be aware of this research as it may lead to new treatment options in the future. Healthcare providers and researchers studying metabolic disease should pay attention to NAMPT as a potential therapeutic target. People without metabolic issues don’t need to take action based on this study. This research is not yet applicable to clinical practice.
This is early-stage research. If NAMPT-targeting drugs are developed, it typically takes 5-10 years of additional research and clinical trials before they become available to patients. Don’t expect treatments based on this discovery in the near future, but stay informed about developments in metabolic disease research.
Frequently Asked Questions
Can I take NAMPT supplements to improve my metabolism and lose weight?
NAMPT supplements are not currently available as medical treatments. This research is in early stages using genetically modified mice. Talk to your doctor about proven weight loss and metabolic health strategies like diet, exercise, and medical supervision.
How does NAMPT help prevent metabolic disease in obesity?
NAMPT produces NAD+, a molecule essential for cellular energy and metabolism. Higher NAMPT levels help fat cells function better, reducing inflammation and improving how the body handles blood sugar. Fat cells also release beneficial molecules through extracellular vesicles that improve metabolism in other tissues.
When will NAMPT-based treatments be available for humans?
This is very early research. If drug development proceeds, it typically takes 5-10 years of additional studies and clinical trials before treatments reach patients. Stay informed through your healthcare provider about emerging metabolic disease therapies.
Does this research mean obesity is caused by low NAMPT?
Low NAMPT contributes to metabolic problems in obesity, but obesity has multiple causes including genetics, diet, activity level, and environment. This research identifies one important factor, not the sole cause. Metabolic health requires addressing multiple factors.
Should I change my diet or exercise routine based on this study?
No. This animal research doesn’t change current medical recommendations. Continue following evidence-based advice: balanced nutrition, regular physical activity, and working with healthcare providers. This research may lead to future treatments, but current lifestyle approaches remain most effective.
Want to Apply This Research?
- Users could track fasting blood glucose levels weekly and monitor changes in energy levels and appetite as potential indicators of metabolic health, creating a baseline for future comparison if NAMPT-based treatments become available.
- Users should focus on evidence-based metabolic health improvements: log daily physical activity (aiming for 150 minutes weekly), track dietary intake to identify high-fat foods, and monitor weight trends. These actions support metabolic health while waiting for future therapeutic developments.
- Establish a long-term tracking system for metabolic markers: monthly weight measurements, quarterly fasting glucose checks (if available), and continuous activity and nutrition logging. This creates a personal health baseline and demonstrates whether current lifestyle interventions are effective.
This research is preliminary and based on animal studies in mice. The findings have not been tested in humans and should not be used to guide personal medical decisions. NAMPT-based treatments are not currently available for clinical use. People with obesity, diabetes, or metabolic disorders should continue following their healthcare provider’s recommendations and not change their treatment based on this research. Always consult with a qualified healthcare professional before making changes to diet, exercise, or medical treatment. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.